AMPKINE LIMITED

Active Cambridge

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
A

AMPKINE LIMITED

Research and experimental development on biotechnology

Founded 24 Jun 2019 Active Cambridge, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

LITHIUM TX LIMITED 22 Apr 2021 — 3 Feb 2025
HYDROGEN TX LIMITED 24 Jun 2019 — 22 Apr 2021
Accounts Submitted 30 Jun 2025 Next due 31 Jul 2026 3 months remaining
Confirmation Submitted 24 Jun 2025 Next due 7 Jul 2026 2 months remaining
Net assets £-3K £753 2024 year on year
Total assets £219 £4 2024 year on year
Total Liabilities £3K £757 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Cambridge Partnership Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3FH England

Full company profile for AMPKINE LIMITED (12065717), an active company based in Cambridge, England. Incorporated 24 Jun 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£219.00

Increased by £4.00 (+2%)

Net Assets

-£3.10k

Decreased by £753.00 (-32%)

Total Liabilities

£3.32k

Increased by £757.00 (+30%)

Turnover

N/A

Employees

N/A

Decreased by 2 (-100%)

Debt Ratio

1516%

Increased by 324 (+27%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 1,900 Shares £30k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Apr 20251,150£11.5£0.01
17 Apr 2025750£30k£40

Officers

Officers

2 active 1 resigned
Status
David John GraingerDirectorBritishEngland5924 Jun 2019Active
The Cambridge Partnership LimitedCorporate-secretaryUnited KingdomUnknown25 Jun 2019Active

Shareholders

Shareholders (8)

Elements Squared Limited
37.5%
750
David Grainger
15.0%
300

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 17 Apr 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

David John Grainger

Ceased 17 Apr 2025

Ceased

Group Structure

Group Structure

AMPKINE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Jun 2025AccountsAnnual accounts made up to 2024-10-31
24 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-23 with updates
28 Apr 2025IncorporationMemorandum Articles
28 Apr 2025ResolutionResolutions
28 Apr 2025CapitalCapital Alter Shares Subdivision
30 Jun 2025 Accounts

Annual accounts made up to 2024-10-31

24 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-23 with updates

28 Apr 2025 Incorporation

Memorandum Articles

28 Apr 2025 Resolution

Resolutions

28 Apr 2025 Capital

Capital Alter Shares Subdivision

Recent Activity

Latest Activity

Annual accounts made up to 2024-10-31

9 months ago on 30 Jun 2025

Confirmation statement made on 2025-06-23 with updates

10 months ago on 24 Jun 2025

Memorandum Articles

12 months ago on 28 Apr 2025

Resolutions

12 months ago on 28 Apr 2025

Capital Alter Shares Subdivision

12 months ago on 28 Apr 2025